{
    "clinical_study": {
        "@rank": "48407", 
        "acronym": "QOLD", 
        "arm_group": [
            {
                "arm_group_label": "Incident PD patients", 
                "description": "First treatment for ESRD by any peritoneal dialysis modality within 30 days prior to or following enrollment (patients may be enrolled prior to commencing first treatment if there is clear indication that the treatment modality is CAPD or APD and they consent in advance to enter the study) and patients who don't have any experience of dialysis treatment before this study"
            }, 
            {
                "arm_group_label": "Prevalent PD patients", 
                "description": "Prevalent peritoneal dialysis(PD) patients who are under peritoneal dialysis treatment more than 6 months"
            }, 
            {
                "arm_group_label": "Prevalent HD patients", 
                "description": "Prevalent hemodialysis(HD) patients who are under hemodialysis treatment more than 6 months"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to evaluate QOL (quality of life) and depression in peritoneal\n      dialysis patients compare to hemodialysis patients and assess hydration effect on QOL and\n      depression over time."
        }, 
        "brief_title": "Quality of Life and Depression in Dialysis Patients", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Kidney Disease Stage 5", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Kidney Diseases", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "In dialysis patients, low QOL and depression affects clinical outcomes such as morbidity and\n      mortality.\n\n      Therefore at the point of treating dialysis patients, It is important to provide not only\n      physical health but also psychosocial health.\n\n      QOL could be decided by physical health (i.e. sign and symptom, laboratory results, death)\n      and psychological health (i.e. fatigue, pain, consciousness of health and satisfaction).\n\n      And also generally it is well known that physical and psychological functions in dialysis\n      patients are decreased.\n\n      And especially depression is common disease in dialysis patients. It is also well known that\n      about from 25 to 50 percent of dialysis patients have depression which could result in low\n      QOL moreover hospitalization, complication, and mortality.\n\n      But there is no QOL and depression study with hydration status. Therefore the investigators\n      would like to explore it.\n\n      The objective of the study is to evaluate QOL(quality of life) and depression in peritoneal\n      dialysis patients compare to hemodialysis patients and assess hydration effect on QOL and\n      depression over time"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Dialysis patients, age from 18 years to 75 years\n\n          -  Incident continuous ambulatory peritoneal dialysis(CAPD) or automated peritoneal\n             dialysis(APD) patients who don't have any experience of dialysis treatment before\n             this study\n\n          -  Prevalent peritoneal dialysis(PD) patients who are  getting peritoneal dialysis\n             treatment more than 6 months\n\n          -  Prevalent hemodialysis (HD) patients who are getting haemodialysis treatment more\n             than 6 months\n\n          -  The subjects who are eligible for 1 year follow up\n\n          -  Written informed consent before any trial related activities\n\n          -  Eligible patients to complete questionnaire\n\n        Exclusion Criteria:\n\n          -  Prognosis for survival less than 3 months\n\n          -  Kidney transplantation less than 15 months\n\n          -  Ineligible patients for questionnaire\n\n          -  Any malignancies and ascites\n\n          -  Any condition which could interfere with the patient's ability to comply with the\n             study protocol\n\n          -  Ineligible to measure BCM\n\n               1. pacemaker, defibrillator\n\n               2. pregnancy or lactation period\n\n               3. amputation\n\n               4. artificial joint"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "1. Incident PD patients group : 250 subjects, First treatment for ESRD by any peritoneal\n             dialysis modality within 30 days prior to or following enrollment (patients may be\n             enrolled prior to commencing first treatment if there is clear indication that the\n             treatment modality is CAPD or APD and they consent in advance to enter the study) and\n             patients who don't have any experience of dialysis treatment before this study\n\n          2. Prevalent PD patients : 250 subjects, Prevalent peritoneal dialysis(PD) patients who\n             are under peritoneal dialysis treatment more than 6 months\n\n          3. Prevalent HD patients : 250 subjects, Prevalent hemodialysis(HD) patients who are\n             under hemodialysis treatment more than 6 months"
            }
        }, 
        "enrollment": {
            "#text": "750", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01668628", 
            "org_study_id": "QOLD_01_052012"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "quality of life", 
            "depression", 
            "BCM", 
            "hydrational status"
        ], 
        "lastchanged_date": "July 10, 2013", 
        "location": {
            "contact": {
                "email": "yu-mi.cho@fmc-asia.com", 
                "last_name": "Yu Mi Cho", 
                "phone": "82-2-2112-8842"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "state": "Seocho-gu", 
                    "zip": "137-701"
                }, 
                "name": "Seoul St. Mary's Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "3", 
        "official_title": "Quality of Life and Depression in Peritoneal Dialysis Patients and Hemodialysis Patients", 
        "overall_contact": {
            "email": "yu-mi.cho@fmc-asia.com", 
            "last_name": "Yu Mi Cho", 
            "phone": "82-2-2112-8842"
        }, 
        "overall_official": {
            "affiliation": "Division of nephrology, The Catholic University of Korea College of Medicine", 
            "last_name": "Yongsoo Kim, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "QOL is assessed via KDQOL SF 1.3 and depression is assessed via BDI at the visit 1 and Visit 2 period.\nVisit 2 period is followed 12 months after Visit 1 period.", 
            "measure": "Change of Kidney Disease Quality of Life Short Form 1.3(KDQOL SF 1.3) score and  Beck Depression Inventory(BDI) score from Visit 1 period", 
            "safety_issue": "No", 
            "time_frame": "28 momths"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01668628"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "QOL is assessed via KDQOL SF 1.3 and depression is assessed via BDI at the visit 1 and Visit 2 period.\nVisit 2 period is followed 12 months after Visit 1 period.", 
                "measure": "Association between QOL(quality of life) and depression", 
                "safety_issue": "No", 
                "time_frame": "28 months"
            }, 
            {
                "measure": "Comparison KDQOL and BDI score of peritoneal dialysis(PD) group with hemodialysis(HD) group", 
                "safety_issue": "No", 
                "time_frame": "28 months"
            }, 
            {
                "description": "Hydration and nutritional status is checked via BCM(body composition monitor) at Visit 1 and Visit 2 period.\n(Overhydration(OH), total body water(TBW), extracellular water(ECW), intracellular water(ICW), Lean tissue Index(LTI), Fat tissue index(FTI))", 
                "measure": "Hydration and nutrition status by BCM(Body composition monitor)", 
                "safety_issue": "No", 
                "time_frame": "28 months"
            }
        ], 
        "source": "Fresenius Medical Care Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fresenius Medical Care Korea", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}